Tildrakizumab Effective for Patients with Psoriasis Unresponsive to Anti-IL17 HCP Live, 14 May 2024 Matteo Megna, MD Credit: ResearchGate Tildrakizumab can be an effective treatment option for patients with psoriasis who are…